The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable to military hardening and integration with communication capabilities to support the medical [Read more]
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate high payoff potential to Counter-WMD (C-WMD) threats, including chemical, biological, radiological, nuclear [Read more]
Dr. Kevin Schully, contractor and chief science officer with Naval Medical Research Center’s (NMRC) Austere environments Consortium for Enhanced Sepsis Outcomes Department (ACESO) recently returned stateside after screening Sailors and Marines deployed [Read more]
The U.S. Army is conducting market research on services to help the U.S. Army Chemical Materials Activity (CMA) to meet its assigned treaty and arms control missions under the Chemical Weapons Convention [Read more]
Influenza pandemics, organophosphate poisoning, opioid overdose, and exposure to ionizing radiation are representative of the broad spectrum of biological, chemical, and radiological (CBR) threats that can significantly impact public health and national [Read more]
The U.S. Army is conducting market research to determine the feasibility of a competitive acquisition and to identify potential sources that can provide a Universal Mobile Tester (UMT) for the military’s Joint [Read more]
New Chemical, Biological, Radiological and Nuclear (CBRN) collective protection tent system components were recently put to the test during an Air Force exercise at Joint Base Langley-Eustis, on June 20. During the [Read more]
Military Veterans may be eligible to receive medical care if they participated in U.S. Army chemical or biological substance testing from 1942 to 1975 and have an injury or disease that they [Read more]
The U.S. Army is conducting market research on partnering to accelerate the development of technologies that will enable personnel to assess, protect and mitigate chemical and biological threats. This Request for Information [Read more]
The Naval Medical Research Unit Two (NAMRU-2) headquartered in Singapore with its main laboratory in Phnom Penh, Cambodia, is at the forefront of the U.S. Department of Defense (DoD)’s disease surveillance and [Read more]
© 2018 STEMAR MEDIA